Skip to main content

Table 1 The UCG parameters at chronic stable phase

From: The impact of mid-wall striate of LGE at interventricular septum to the beta-broker (Carvedilol) titrating to the target dose and the improvement of cardiac function with DCM

MWS-LGE

LVDd(mm)

LVDs(mm)

EF(%)

Negative

54.4+/-7.7

39.8+/-9.9

52.3+/-14.2

Positive

63.1+/-10.9

52.4+/-14.8

36.2+/-18.1

P-value

<0.02

<0.02

<0.01